The Use of Biomarkers for Alzheimer's Disease in Primary Care
Using imaging studies, primarily PET, as well as
cerebrospinal fluid (CSF) and even blood biomarkers for beta amyloid and tau,
the pathologic drivers of AD, clinicians can identify patients with AD
pathology before any symptoms are present. |